Search Results - "COUPE, V. M. H."

High-Risk Human Papillomavirus (hrHPV) E6/E7 mRNA Testing by PreTect HPV-Proofer for Detection of Cervical High-Grade Intraepithelial Neoplasia and Cancer among hrHPV DNA-Positive Women with Normal Cytology by RIJKAART, D. C, HEIDEMAN, D. A. M, COUPE, V. M. H, BRINK, A. A. T. P, VERHEIJEN, R. H. M, SKOMEDAL, H, KARLSEN, F, MORLAND, E, SNIJDERS, P. J. F, MEIJER, C. J. L. M

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis by Goos, J A C M, Coupe, V M H, Diosdado, B, Delis-Van Diemen, P M, Karga, C, Beliën, J A M, Carvalho, B, van den Tol, M P, Verheul, H M W, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A

“…Background: Five-year survival after resection of colorectal cancer liver metastasis (CRLCM) is <30%. We recently found that aurora kinase A (AURKA) drives 20q…”
Get full text

pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited by Snaebjornsson, P., Coupe, V.M.H., Jonasson, L., Meijer, G.A., Grieken, N.C., Jonasson, J.G.

“…The aim of this study is to clarify the prognostic importance of several well‐known but still debated pathological variables related to the survival of colon…”
Get full text

Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis by van den Boorn, H G, Engelhardt, E G, van Kleef, J, Sprangers, M A G, van Oijen, M G H, Abu-Hanna, A, Zwinderman, A H, Coupé, V M H, van Laarhoven, H W M

“…Clinical prediction models are increasingly used to predict outcomes such as survival in cancer patients. The aim of this study was threefold. First, to…”
Get full text

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening by Coupé, V M H, Berkhof, J, Bulkmans, N W J, Snijders, P J F, Meijer, C J L M

“…We determined the prevalence of type-specific hrHPV infections in the Netherlands on cervical scrapes of 45 362 women aged 18–65 years. The overall hrHPV…”
Get full text

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design by Wisse, P H A, de Klaver, W, van Wifferen, F, Meiqari, L, Bierkens, M, Greuter, M J E, Carvalho, B, van Leerdam, M E, Spaander, M C W, Dekker, E, Coupé, V M H, de Wit, M, Meijer, G A

“…Many screening programs for colorectal cancer (CRC) use the fecal immunochemical test (FIT) to triage individuals for colonoscopy. Although these programs…”
Get full text

Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing by Vessies, D. C. L., Greuter, M. J. E., van Rooijen, K. L., Linders, T. C., Lanfermeijer, M., Ramkisoensing, K. L., Meijer, G. A., Koopman, M., Coupé, V. M. H., Vink, G. R., Fijneman, R. J. A., van den Broek, D.

“…Multiple platforms are commercially available for the detection of circulating cell-free tumour DNA (ctDNA) from liquid biopsies. Since platforms have…”
Get full text

Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer by de Cuba, E. M. V., de Hingh, I. H. J. T., Sluiter, N. R., Kwakman, R., Coupé, V. M. H., Beliën, J. A. M., Verwaal, V. J., Meijerink, W. J. H. J., Delis-van Diemen, P. M., Bonjer, H. J., Meijer, G. A., te Velde, E. A.

“…Background Patients presenting with peritoneal metastases (PM) of colorectal cancer (CRC) can be curatively treated with cytoreductive surgery (CRS) and…”
Get full text

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy by Sluiter, N. R., de Cuba, E. M. V., Kwakman, R., Meijerink, W. J. H. J., Delis-van Diemen, P. M., Coupé, V. M. H., Beliën, J. A. M., Meijer, G. A., de Hingh, I. H. J. T., te Velde, E. A.

“…Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can increase survival of colorectal cancer (CRC) patients with peritoneal…”
Get full text

Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation by Eekman, D. A., ter Wee, M. M., Coupé, V. M. H., Erisek-Demirtas, S., Kramer, M. H., Lems, W. F.

“…Summary Data on direct and indirect costs of clinical fractures in 116 osteoporotic patients 50 years and older were prospectively collected using cost…”
Get full text

Cost‐effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia by Coupé, VMH, Berkhof, J, Verheijen, RHM, Meijer, CJLM

“…Objective  To compare current cytological follow up of women treated for high‐grade cervical intraepithelial neoplasia (CIN) with follow up by high‐risk human…”
Get full text

Decision support systems for incurable non-small cell lung cancer: a systematic review by Révész, D, Engelhardt, E G, Tamminga, J J, Schramel, F M N H, Onwuteaka-Philipsen, B D, van de Garde, E M W, Steyerberg, E W, Jansma, E P, De Vet, H C W, Coupé, V M H

“…Individually tailored cancer treatment is essential to ensure optimal treatment and resource use. Treatments for incurable metastatic non-small cell lung…”
Get full text

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications by Rijkaart, D C, Berkhof, J, van Kemenade, F J, Coupe, V M H, Rozendaal, L, Heideman, D A M, Verheijen, R H M, Bulk, S, Verweij, W, Snijders, P J F, Meijer, C J L M

“…Background: Human papillomavirus (HPV) testing is more sensitive than cytology for detecting high-grade cervical intraepithelial neoplasia (CIN). We evaluated…”
Get full text

Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers by de Cuba, E.M.V., Snaebjornsson, P., Heideman, D.A.M., van Grieken, N.C.T., Bosch, L.J.W., Fijneman, R.J.A., Belt, E., Bril, H., Stockmann, H.B.A.C., Hooijberg, E., Punt, C.J.A., Koopman, M., Nagtegaal, I.D., Coupé, V.H.M., Carvalho, B., Meijer, G.A.

“…Microsatellite instability (MSI) has been associated with favourable survival in early stage colorectal cancer (CRC) compared to microsatellite stable (MSS)…”
Get full text

Costs of non-small cell lung cancer in the Netherlands by van der Linden, N, Bongers, M.L, Coupé, V.M.H, Smit, E.F, Groen, H.J.M, Welling, A, Schramel, F.M.N.H, Uyl-de Groot, C.A

“…Highlights • Mean hospital costs per NSCLC patient are €33,143 for the entire disease duration. • The estimated €33,143 per patient is similar to other…”
Get full text

Multistate Statistical Modeling: A Tool to Build a Lung Cancer Microsimulation Model That Includes Parameter Uncertainty and Patient Heterogeneity by Bongers, Mathilda L., de Ruysscher, Dirk, Oberije, Cary, Lambin, Philippe, Uyl–de Groot, Carin A., Coupé, V. M. H.

“…With the shift toward individualized treatment, cost-effectiveness models need to incorporate patient and tumor characteristics that may be relevant to…”
Get full text

Colonoscopy‐controlled intra‐individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac‐based faecal occult blood test by OORT, F. A., TERHAAR SIVE DROSTE, J. S., VAN DER HULST, R. W. M., VAN HEUKELEM, H. A., LOFFELD, R. J. L. F., WESDORP, I. C. E., VAN WANROOIJ, R. L. J., DE BAAIJ, L., MUTSAERS, E. R., VAN DER REIJT, S., COUPE, V. M. H., BERKHOF, J., BOUMAN, A. A., MEIJER, G. A., MULDER, C. J. J.

“…Aliment Pharmacol Ther 31, 432–439 Summary Background  Guaiac‐based faecal occult blood tests (g‐FOBTs) are most commonly used in colorectal cancer (CRC)…”
Get full text

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases by Goos, J A C M, Hiemstra, A C, Coupé, V M H, Diosdado, B, Kooijman, W, Delis-Van Diemen, P M, Karga, C, Beliën, J A M, Menke-van der Houven van Oordt, C W, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A

“…Background: Resection of colorectal cancer liver metastasis (CRCLM) with curative intent has long-term benefit in ∼40% of cases. Prognostic biomarkers are…”
Get full text

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test by Rijkaart, D C, Coupe, V M H, van Kemenade, F J, Heideman, D A M, Hesselink, A T, Verweij, W, Rozendaal, L, Verheijen, R H, Snijders, P J, Berkhof, J, Meijer, C J L M

“…Background: We evaluated the performance of primary high-risk human papillomavirus (hrHPV) testing by hybrid capture 2 (HC2) with different thresholds for…”
Get full text

Aberrant T‐lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization by Verbeek, W.H.M., von Blomberg, B.M.E., Coupe, V.M.H., Daum, S., Mulder, C.J.J., Schreurs, M.W.J.

“…Background: Refractory coeliac disease (RCD) is characterized by persisting mucosal pathology in spite of a strict gluten free diet (GFD). In RCD type II,…”
Get full text